NEVVI Medicare utilization intelligence

Geography — Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (Q5118) in Medicare, the United States

Geography · Q5118 · National · CY2024 Geography: 14 states
The full market analysis — how large this market is in Medicare dollars, who holds most of the volume, and how it is moving. See the full market analysis → or start a trial
Where Q5118 is billed · every state market

Every state market that bills this code, by services, each linked to its own market page.

← Back to the market overview